Kurs Caraco Pharmaceutical Laboratories Ltd.

Aktien

Schlusskurs NYSE
- ^USD	-

14.06.11	Caraco Pharmaceutical Laboratories Ltd. : Caraco Announces Stockholder Approval of Merger Agreement with Sun Pharma and Consummation of the Merger
22.02.11	Caraco Pharmaceutical Laboratories Ltd. : Caraco Announces Merger Agreement with Sun Pharma; Caraco Public Shareholders to Receive $5.25 Cash per Share
30.01.11	Caraco Pharmaceutical Laboratories Ltd. : Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal Year 2011
07.12.10	Caraco Pharmaceutical Laboratories Ltd. : The Law Office of Abe Shainberg Launches an Investigation into the Possible Breaches of Fiduciary Duty by the Board of Caraco Pharmaceutical Laboratories Ltd. in Connection with the Sale of the Company to Sun Pharmaceutical Industries – CPD
07.12.10	Caraco Pharmaceutical Laboratories Ltd. : Law Office of Brodsky & Smith, LLC Announces Investigation of Caraco Pharmaceutical Laboratories Ltd.

Zu einer Liste hinzufügen 0 ausgewählt Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein Einloggen Anmeldung	%	% 5 Tage	Perf. 1 Jahr	Perf. 3 Jahre	Marktkap.($)
ELI LILLY AND COMPANY	+3.19%	+11.31%	+64.28%	+155.91%	1’263 Mrd.
JOHNSON & JOHNSON	-0.73%	+3.56%	+44.65%	+84.17%	658 Mrd.
ABBVIE INC.	+1.41%	+3.24%	+35.25%	+108.88%	521 Mrd.
ROCHE HOLDING AG	+0.42%	+3.20%	+55.81%	+72.50%	391 Mrd.
MERCK & CO., INC.	+2.18%	+2.93%	+73.90%	+45.59%	369 Mrd.
NOVARTIS AG	+1.12%	+4.52%	+34.76%	+58.24%	307 Mrd.
ASTRAZENECA PLC	+6.96%	+8.86%	+11.95%	+36.20%	290 Mrd.
AMGEN INC.	+1.15%	+6.09%	+56.15%	+82.25%	252 Mrd.
GILEAD SCIENCES, INC.	+3.06%	+9.38%	+42.48%	+117.32%	212 Mrd.
Durchschnitt	+2.08%	+5.90%	+46.58%	+84.56%	473.55 Mrd.
Nach Marktkapitalisierung gewichteter Durchschnitt	+2.01%	+6.60%	+50.51%	+100.44%